Literature DB >> 27872155

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

.   

Abstract

Entities:  

Year:  2016        PMID： 27872155     DOI： 10.2337/dc16-2215

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  177 in total

1.  Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.

Authors:  Richard M Bergenstal; Mary Johnson; Rebecca Passi; Anuj Bhargava; Natalie Young; Davida F Kruger; Eran Bashan; Stanley G Bisgaier; Deanna J Marriott Isaman; Israel Hodish
Journal:  Lancet       Date:  2019-02-23       Impact factor: 79.321

Review 2.  Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes.

Authors:  T W Jones
Journal:  Pediatr Diabetes       Date:  2017-10-30       Impact factor: 4.866

3.  The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman
Journal:  Diabetes Technol Ther       Date:  2018-12-21       Impact factor: 6.118

4.  Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Authors:  Malin Nilsson; Nicole Jensen; Michael Gejl; Marianne L Bergmann; Heidi Storgaard; Mette Zander; Kamilla Miskowiak; Jørgen Rungby
Journal:  Diabetologia       Date:  2019-07-31       Impact factor: 10.122

5.  Assessment of Glucose Control Metrics by Discriminant Ratio.

Authors:  Vanessa Moscardó; Pau Herrero; Monika Reddy; Nathan R Hill; Pantelis Georgiou; Nick Oliver
Journal:  Diabetes Technol Ther       Date:  2020-10       Impact factor: 6.118

Review 6.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

7.  A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study.

Authors:  Chengyuan Liu; Parizad Avari; Yenny Leal; Marzena Wos; Kumuthine Sivasithamparam; Pantelis Georgiou; Monika Reddy; José Manuel Fernández-Real; Clare Martin; Mercedes Fernández-Balsells; Nick Oliver; Pau Herrero
Journal:  J Diabetes Sci Technol       Date:  2019-05-22

8.  Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman; Zhaomian Li; Adam S Brown; Kelly L Close
Journal:  Diabetes Care       Date:  2018-10-23       Impact factor: 19.112

9.  Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.

Authors:  Dawei Shi; Eyal Dassau; Francis J Doyle
Journal:  IEEE Trans Biomed Eng       Date:  2018-08-21       Impact factor: 4.538

10.  Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin.

Authors:  Allison Zuern; Luke A Probst; William Darko; Peter Rosher; Christopher D Miller; Lori Gordon; Robert Seabury
Journal:  Hosp Pharm       Date:  2019-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.